first glp-1 approval FDA UPDATE: A new oral medication has been approved 🚨 For the time, patients now have an FDA-approved oral option for medical weight management—expanding choices beyond injectable treatments. This breakthrough GLP-1 RA prescription trends: January

Experimental studies have explored interactions involving fibroblast activity, vascular signalling, collagen synthesis, nitric oxide pathways and cellular communication

On days when you feel good, prep meals for days when you dont

The affected medications include: Semaglutide (Ozempic, Rybelsus, Wegovy) Liraglutide (Saxenda, Victoza) Tirzepatide (Mounjaro, Zepbound) New Warning Details The updated label now includes a subsection under "Warnings and Precautions" that states: "There have been rare postmarketing reports of pulmonary aspiration in patients receiving GLP-1 receptor agonists undergoing elective surgeries or procedures requiring general anesthesia or deep sedation who had residual gastric contents despite reported adherence to preoperative fasting recommendations." This warning highlights the potential risk of stomach contents entering the lungs during surgical procedures, even when patients have followed fasting guidelines

381 This may be caused by dysfunction of the transcription factor EB-P300-bromodomain-containing protein 4 axis